Research/art/teacher profile of a person
Name and surname:
PharmDr. Katarína Hadová, PhD.
Document type:
Research/art/teacher profile of a person
The name of the university:
Comenius University Bratislava
The seat of the university:
Šafárikovo námestie 6, 818 06 Bratislava

I. - Basic information

I.1 - Surname
Hadová
I.2 - Name
Katarína
I.3 - Degrees
PharmDr., PhD.
I.4 - Year of birth
1992
I.5 - Name of the workplace
Dpt. of Pharmacology and Toxicology
I.6 - Address of the workplace
Odbojarov 10, 832 32 Bratislava
I.7 - Position
Assistant Professor
I.8 - E-mail address
hadova3@uniba.sk
I.9 - Hyperlink to the entry of a person in the Register of university staff
https://www.portalvs.sk/regzam/detail/34269
I.10 - Name of the study field in which a person works at the university
Pharmacy
I.11 - ORCID iD
0000-0001-7055-9561

II. - Higher education and further qualification growth

II.1 - First degree of higher education
II.2 - Second degree of higher education
II.a - Name of the university or institution
Faculty of Pharmacy, Comenius University Bratislava
II.b - Year
2017
II.c - Study field and programme
Pharmacy/Pharmacy
II.3 - Third degree of higher education
II.a - Name of the university or institution
Faculty of Pharmacy, Comenius University Bratislava
II.b - Year
2021
II.c - Study field and programme
field of study Pharmacy, studies programme Pharmacology
II.4 - Associate professor
II.5 - Professor
II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

III.a - Occupation-position III.b - Institution III.c - Duration
pharmacist Retail Pharmacy Bratislava 09/2019-08/2020; 08/2021-12/2021
pharmacist Pharmacy Schneider Liptovský Mikuláš 07-08/2017

IV. - Development of pedagogical, professional, language, digital and other skills

IV.a - Activity description, course name, other IV.b - Name of the institution IV.c - Year
German language course Universität Innsbruck 2018

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes
V.1.a - Name of the profile course V.1.b - Study programme V.1.c - Degree V.1.d - Field of study
Pharmacology Pharmacy I.II. Pharmacy
V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year
V.2.a - Name of the study programme V.2.b - Degree V.2.c - Field of study
Pharmacy I.II. Pharmacy
Medical and Diagnostic devices I. Medical and Diagnostic devices
V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year
V.4 - Overview of supervised final theses
V.4.1 - Number of currently supervised theses
V.4.a - Bachelor's (first degree)
0
V.4.b - Diploma (second degree)
1
V.4.c - Dissertation (third degree)
0
V.4.2 - Number of defended theses
V.4.a - Bachelor's (first degree)
0
V.4.b - Diploma (second degree)
5
V.4.c - Dissertation (third degree)
0
V.5 - Overview of other courses taught in the current academic year according to study programmes
V.5.a - Name of the course V.5.b - Study programme V.5.c - Degree V.5.d - Field of study
General Biology (Mgr.) Pharmacy I.II. Pharmacy
Anatomy and Physiology (Mgr.) Pharmacy I.II. Pharmacy
Biology (Bc.) Medical and Diagnostic Devices I. Medical and Diagnostic Devices
General Biology Pharmacy I.II. Pharmacy
Anatomy and Physiology Pharmacy I.II. Pharmacy
Toxicology (Mgr.) Pharmacy I.II. Pharmacy
Toxicology Pharmacy I.II Pharmacy

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations
VI.1.1 - Number of the research/artistic/other outputs
VI.1.a - Overall
33
VI.1.b - Over the last six years
33
VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases
VI.1.a - Overall
15
VI.1.b - Over the last six years
15
VI.1.3 - Number of citations corresponding to the research/artistic/other outputs
VI.1.a - Overall
33
VI.1.b - Over the last six years
33
VI.1.4 - Number of citations registered in the Web of Science or Scopus databases
VI.1.a - Overall
33
VI.1.b - Over the last six years
33
VI.1.5 - Number of invited lectures at the international, national level
VI.1.a - Overall
0
VI.1.b - Over the last six years
0
VI.2 - The most significant research/artistic/other outputs
1

Hadova et al. Isolated downregulation of HCN2 in ventricles of rats with streptozotocin-induced diabetic cardiomyopathy In: BMC Cardiovascular Disorders [elektronický dokument]. - Roč. 21, č. 1 (2021), s. [1-11], art.no. 118 [online]. - ISSN (online) 1471-2261

2

Hadova et al. The tyrosine kinase inhibitor crizotinib influences blood glucose and mRNA expression of GLUT4 and PPARs in the heart of rats with experimental diabetes In: Canadian Journal of Physiology and Pharmacology [elektronický dokument]. - Roč. 99, č. 6 (2021), s. 635-643 [print]

3

Contractile Effects of Semaglutide in the Human Atrium / Neumann, Joachim (Korešpondenčný autor) (25%) ; Hadová, Katarína (Autor) (25%) ; Klimas, Ján (Autor) (25%) ; Gergs, Ulrich (Autor) (25%). – [recenzované]. – DOI 10.3390/pharmaceutics16091139. – WOS CC ; SCO

In: Pharmaceutics [elektronický dokument] . – Bazilej (Švajčiarsko) : Multidisciplinary Digital Publishing Institute. – ISSN (online) 1999-4923. – Roč. 16, č. 9 (2024), art. no. 1139, s. [1-13] [online]

4

Hadova K, Kmecova J, Ochodnicka-Mackovicova K, Kralova E, Doka G, Bies Pivackova L, Vavrinec P, Stankovicova T, Krenek P, Klimas J. Rapid changes of mRNA expressions of cardiac ion channels affected by Torsadogenic drugs influence susceptibility of rat hearts to arrhythmias induced by Beta-Adrenergic stimulation. Pharmacol Res Perspect. 2023 Oct;11(5):e01134. doi: 10.1002/prp2.1134. PMID: 37715323; PMCID: PMC10504435.

5

Initial Characterization of a Transgenic Mouse with Overexpression of the Human H1-Histamine Receptor on the Heart / Rayo Abella, Lina Maria (Autor) (6.676%) ; Jacob, Hannes (Autor) (6.666%) ; Keller, Max (Autor) (6.666%) ; Schindler, Lisa (Autor) (6.666%) ; Pockes, Steffen (Autor) (6.666%) ; Pitzl, Sebastian (Autor) (6.666%) ; Klimas, Ján (Autor) (6.666%) ; Hadová, Katarína (Autor) (6.666%) ; Schneider, Sarah (Autor) (6.666%) ; Buchwalow, Igor B. (Autor) (6.666%) ; Jin, CongYu (Autor) (6.666%) ; Panula, Pertti (Autor) (6.666%) ; Kirchhefer, Uwe (Autor) (6.666%) ; Neumann, Joachim (Korešpondenčný autor) (6.666%) ; Gergs, Ulrich (Autor) (6.666%). – [recenzované]. – DOI 10.1124/jpet.123.002060. – SCO

In: Journal of Pharmacology and Experimental Therapeutics [textový dokument (print)] [elektronický dokument] . – Bethesda (USA) : American Society for Pharmacology and Experimental Therapeutics. – ISSN 0022-3565. – ISSN (online) 1521-0103. – Roč. 389, č. 2 (2024), s. 174-185 [tlačená forma] [online]

VI.3 - The most significant research/artistic/other outputs over the last six years
1

Hadova et al. Isolated downregulation of HCN2 in ventricles of rats with streptozotocin-induced diabetic cardiomyopathy In: BMC Cardiovascular Disorders [elektronický dokument]. - Roč. 21, č. 1 (2021), s. [1-11], art.no. 118 [online]. - ISSN (online) 1471-2261

2

Hadova et al. The tyrosine kinase inhibitor crizotinib influences blood glucose and mRNA expression of GLUT4 and PPARs in the heart of rats with experimental diabetes In: Canadian Journal of Physiology and Pharmacology [elektronický dokument]. - Roč. 99, č. 6 (2021), s. 635-643 [print]

3

Contractile Effects of Semaglutide in the Human Atrium / Neumann, Joachim (Korešpondenčný autor) (25%) ; Hadová, Katarína (Autor) (25%) ; Klimas, Ján (Autor) (25%) ; Gergs, Ulrich (Autor) (25%). – [recenzované]. – DOI 10.3390/pharmaceutics16091139. – WOS CC ; SCO

In: Pharmaceutics [elektronický dokument] . – Bazilej (Švajčiarsko) : Multidisciplinary Digital Publishing Institute. – ISSN (online) 1999-4923. – Roč. 16, č. 9 (2024), art. no. 1139, s. [1-13] [online]

4

Hadova K, Kmecova J, Ochodnicka-Mackovicova K, Kralova E, Doka G, Bies Pivackova L, Vavrinec P, Stankovicova T, Krenek P, Klimas J. Rapid changes of mRNA expressions of cardiac ion channels affected by Torsadogenic drugs influence susceptibility of rat hearts to arrhythmias induced by Beta-Adrenergic stimulation. Pharmacol Res Perspect. 2023 Oct;11(5):e01134. doi: 10.1002/prp2.1134. PMID: 37715323; PMCID: PMC10504435.

5

Initial Characterization of a Transgenic Mouse with Overexpression of the Human H1-Histamine Receptor on the Heart / Rayo Abella, Lina Maria (Autor) (6.676%) ; Jacob, Hannes (Autor) (6.666%) ; Keller, Max (Autor) (6.666%) ; Schindler, Lisa (Autor) (6.666%) ; Pockes, Steffen (Autor) (6.666%) ; Pitzl, Sebastian (Autor) (6.666%) ; Klimas, Ján (Autor) (6.666%) ; Hadová, Katarína (Autor) (6.666%) ; Schneider, Sarah (Autor) (6.666%) ; Buchwalow, Igor B. (Autor) (6.666%) ; Jin, CongYu (Autor) (6.666%) ; Panula, Pertti (Autor) (6.666%) ; Kirchhefer, Uwe (Autor) (6.666%) ; Neumann, Joachim (Korešpondenčný autor) (6.666%) ; Gergs, Ulrich (Autor) (6.666%). – [recenzované]. – DOI 10.1124/jpet.123.002060. – SCO

In: Journal of Pharmacology and Experimental Therapeutics [textový dokument (print)] [elektronický dokument] . – Bethesda (USA) : American Society for Pharmacology and Experimental Therapeutics. – ISSN 0022-3565. – ISSN (online) 1521-0103. – Roč. 389, č. 2 (2024), s. 174-185 [tlačená forma] [online]

VI.4 - The most significant citations corresponding to the research/artistic/other outputs
1

Adoga, J.O. et al. Kolaviron attenuates cardiovascular injury in fructose-streptozotocin induced type-2 diabetic male rats by reducing oxidative stress, inflammation, and improving cardiovascular risk markers In: Biomedicine and Pharmacotherapy. (2021) 144,112323 Scopus

2

Panagiotis Theofilis, Marios Sagris, Evangelos Oikonomou, Alexios S Antonopoulos, Gerasimos Siasos, Konstantinos Tsioufis, Dimitris Tousoulis,

The impact of SGLT2 inhibitors on inflammation: A systematic review and meta-analysis of studies in rodents,

International Immunopharmacology,

Volume 111,

2022,

109080,

ISSN 1567-5769,

https://doi.org/10.1016/j.intimp.2022.109080

Scopus

3

Uddin, M.E. et al. Contribution of membrane transporters to chemotherapy-induced cardiotoxicity In: Basic and Clinical Pharmacology and Toxicology. (2022)130(S1), pp. 36-47 Scopus

4

Kong, L. et al. Chlorogenic acid and caffeine combination attenuates adipogenesis by regulating fat metabolism and inhibiting adipocyte differentiation in 3T3-L1 cells In Journal of Food Biochemistry. (2021)  Jul;45(7):e13795 Scopus

5

Zhao, Q. et al. Recent advances in metabolism and toxicity of tyrosine kinase inhibitors In: Pharmacology and Therapeutics.(2022) 237 108256 Scopus

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years
1

VEGA: 1/0004/18 Prevention of Development of Cardiorenal Syndrome in Experimental model of Diabetes mellitus by SGLT2 Transporter and PPAR gamma Receptor Modulation

2

APVV-15-0685 Teranostic Potential of Components of Alternative RAS in Modulation of Right Ventricular Function and Dysfunction

3

VEGA 1/0195/20 The role of hepatocyte growth factor in development and progression of diabetic cardiomyopathy

4

UK/146/2020 Expression of HCN channels in the cell line of rat myoblasts in interventions simmulating pathological changes in diabetes mellitus

5

APVV-19-0458 Konvergencia sérotonínu a rastových faktorov súvisiacich s pľúcnou hypertenziou v modulácii pravokomorovej funkcie a zlyhania

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

VIII.a - Name of the institution VIII.b - Address of the institution VIII.c - Duration (indicate the duration of stay) VIII.d - Mobility scheme, employment contract, other (describe)
Institut für Pharmakologie und Toxikologie, Westfälische Wilhelms-Universität Münster Münster, Germany 01/09/2020 - 28/02/2021 scientific internship
Institut für Pharmakologie und Toxikologie, Medizinische Fakultät der Martin-Luther-Universität Halle- Wittenberg Halle (Saale), Germany 13/02/2023 - 21/02/2023 business trip
20.11. 2023 - 24..11. 2023 Halle (Saale), Germany 20.11. 2023 - 24..11. 2023 business trip

IX. - Other relevant facts

Date of last update
2024-03-07